Biotech Marketing Materials and Assets for Life Science Companies
Biotech marketing materials are the decks, documents, and visual assets your team uses to explain its technology to investors, partners, and customers. Across biotechnology, diagnostics, instrumentation, CRO, and platform companies, the same set of assets has to do two jobs at once: keep the science accurate and make the commercial value land. Biond builds materials that do both, as single assets or as a coordinated package.
Each asset can stand alone, or build on the others
Alone, each piece makes its own impression. Built on one system, your deck, application note, booth, and website carry the same message and reinforce each other.
The raise
The science
The room
The front door
Marketing materials that hold up to a scientific reader
A piece of collateral works inside a narrow window of attention. An investor skims a deck before a first call, a partner scans a one-pager to see whether your platform fits their pipeline, a scientist gives a booth three seconds. In each case the material has to make the technology and its commercial value legible fast, without thinning the science to the point where a knowledgeable reader loses confidence.
Most life science marketing materials fail in one of two ways: the science is precise but the commercial relevance never lands, or the design looks polished while the claims get diluted into something a scientific reviewer would not stand behind. Biond builds the commercial message outward from the science, so the claims are ones your team and advisors are comfortable putting their name to, and the framing still does commercial work. That is hard to get from a generalist agency that treats the science as a detail to smooth over.
The biotech marketing materials we build for life science teams
A full range of biotech marketing materials, available as single assets or as a coordinated package. Each piece is built on your positioning so the message holds from one format to the next and every asset reinforces the rest.
Investor & pitch decks
Fundraising decks and data narratives sequenced to answer what scientific and commercial investors actually ask.
Application notes & white papers
Technical write-ups and scientific posters that present data credibly to a scientific reader.
Booth, poster & tradeshow
Visuals built to register on a busy exhibition floor and give the right person a reason to stop.
Website & digital assets
Pages, one-pagers, and content that introduce the company and its technology to first-time readers.
All assets are built to reinforce your positioning and create recognition with scientific and commercial audiences.
How the assets get used
Business development & partnering
Clear one-pagers, sales decks, and capability documents help potential partners see how your platform fits their priorities, shortening the early back and forth.
Conferences & tradeshows
Booth visuals, posters, and presentations turn complex science into messages that register in a crowded environment, giving the right person a reason to pause at your booth, and you a moment to connect.
Explore conference booth designInvestor meetings & fundraising
Pitch decks and supporting materials help investors understand the technology, the opportunity, and progress to date, in a sequence that answers what scientific and commercial investors actually ask.
Explore investor deck supportDigital presence & content marketing
Website assets and LinkedIn content are often the first introduction to a company. They need to explain what the technology is and why it matters before anyone reaches out.
Explore web design Explore content marketingStart with a conversation
Start with a conversation without obligations, just to get to know how we work with life science companies.
Frequently asked questions
Biond produces the full range of biotech marketing materials: investor and pitch decks, corporate presentations, one-pagers, brochures, application notes, white papers, scientific posters, booth and tradeshow visuals, website assets, and webinar materials. All are designed to make your company easier to understand, trust, and act on, whether the reader is an investor, a partner, or a technical buyer.
Biond produces both standalone assets and coordinated marketing packages. Many biotech startups begin with a single deck or one-pager, which is still built on your existing positioning so it stays consistent with the rest of your communication. A bundled package suits teams preparing a raise, a launch, or a conference season, where the deck, website assets, and printed materials need to carry one message.
Biond works only with life science and biotechnology companies, so your materials are judged on scientific accuracy as well as design. A generalist agency can make materials look professional, but it often cannot tell whether a technical claim is accurate, well supported, or framed in a way a scientific buyer will trust. Biond builds the commercial message outward from the science, so the result holds up to a technical reader and a commercial one.
Biond works mostly with life science companies that need scientific credibility and commercial results: diagnostics and biotech platform companies, CROs and CDMOs, scientific instrument and genomics businesses, and research service providers. The materials are written to hold up scientifically while staying useful and engaging for non-technical audiences such as investors, partners, and procurement teams.
Timelines depend on the asset and the starting point. A single deck or one-pager built on settled positioning can move quickly, while a coordinated package, or work that also needs to clarify positioning first, takes longer. A short scoping conversation is the fastest way to get a realistic timeline for your specific materials.